An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin

por Poordad, Fred, Lawitz, Eric, Gutierrez, Julio A., Guerrero, Juan, Speeg, Kermit, Swenson, Eugene S.
Publicado 2017

Adipose tissue measurement in clinical research for obesity, type 2 diabetes and NAFLD/NASH

por Vilalta, Adrian, Gutiérrez, Julio A., Chaves, SuZanne, Hernández, Moisés, Urbina, Silvia, Hompesch, Marcus
Publicado 2022

Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study

por Lawitz, Eric, Poordad, Fred, Gutierrez, Julio A., Beumont, Maria, Beets, Greet, Vandevoorde, Ann, Remoortere, Pieter Van, Luo, Donghan, Vijgen, Leen, Eygen, Veerle Van, Gamil, Mohamed
Publicado 2020

Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/...

por Gane, Edward, de Ledinghen, Victor, Dylla, Douglas E., Rizzardini, Giuliano, Shiffman, Mitchell L., Barclay, Stephen T., Calleja, Jose Luis, Xue, Zhenyi, Burroughs, Margaret, Gutierrez, Julio A.
Publicado 2021